Skip to content
Clinical Trials – home

Pulmonary venous thrombosis

1 / 1 trials open to patients2 countries

In short

Pulmonary venous thrombosis is a rare but potentially life-threatening condition where blood clots form in the veins that carry oxygen-rich blood from the lungs to the heart. Unlike the more common blood clots in the legs, this condition often goes unnoticed until serious complications occur.

What Is Pulmonary Venous Thrombosis?

Pulmonary venous thrombosis is a condition where blood clots form in the pulmonary veins—the blood vessels that carry oxygen-rich blood from the lungs back to the heart. These are the most proximal source of arterial blood clots, meaning clots that form here can travel to other parts of the body through the arterial system.

This condition is rare and often underdiagnosed in clinical practice. The true number of cases is unclear, as most medical literature consists of individual case reports rather than large studies. One reason for its rarity is that the lungs have a rich network of backup veins that help drain blood, though certain medical situations can lead to blockages.

Historical autopsy studies have shown that this condition was underdetected in the past, suggesting it may be more common than previously thought but simply not recognized during life.

What Causes This Condition?

Several mechanisms can lead to blood clot formation in the pulmonary veins. The most probable cause is direct injury to the vein, though mechanical factors and twisting of blood vessels can also play a role.

Pulmonary venous thrombosis most commonly occurs as a complication of specific medical situations:

  • Lung surgery, particularly during the early period following lobectomy (surgical removal of part of the lung), especially left upper lobectomy
  • Lung transplantation, often affecting the area where the pulmonary vein is surgically connected
  • Metastatic cancer (cancer that has spread from another part of the body)
  • Atrial fibrillation (an irregular heart rhythm)

In some cases, no clear cause can be identified, and these are described as idiopathic.

Signs and Symptoms

Many patients with pulmonary venous thrombosis have no obvious symptoms, which makes the condition difficult to detect. When symptoms do appear, they are often nonspecific, meaning they could be caused by many different conditions.

The most common symptoms include:

  • Cough
  • Hemoptysis (coughing up blood)
  • Dyspnea (shortness of breath or difficulty breathing)

These symptoms typically result from pulmonary edema (fluid buildup in the lungs) or pulmonary infarction (damage to lung tissue due to blocked blood flow).

Because the symptoms are not specific to this condition, doctors must maintain a high level of suspicion to make the correct diagnosis, especially in patients who have recently had lung surgery or have other risk factors.

How Is It Diagnosed?

Diagnosing pulmonary venous thrombosis is often challenging and requires advanced imaging techniques. The condition can be easily missed if healthcare providers do not specifically look for it.

Blood clots in the pulmonary veins are typically detected using one or more of the following imaging methods:

  • Transesophageal echocardiogram (TEE)—an ultrasound test performed by inserting a probe down the throat to get detailed images of the heart and nearby blood vessels
  • Computed tomography (CT) scanning—a specialized X-ray technique that creates detailed cross-sectional images of the body
  • Magnetic resonance imaging (MRI)—a test that uses powerful magnets and radio waves to create detailed images
  • Pulmonary angiography—an X-ray test that uses contrast dye to visualize blood vessels in the lungs

Accurate and prompt diagnosis requires a high index of suspicion from healthcare providers, particularly in patients with known risk factors such as recent lung surgery or cancer.

Potential Complications

Without timely identification and proper treatment, pulmonary venous thrombosis can lead to serious, potentially life-threatening complications.

Possible complications include:

  • Pulmonary infarction (death of lung tissue due to lack of blood supply)
  • Pulmonary edema (dangerous fluid accumulation in the lungs)
  • Right ventricular failure (when the right side of the heart cannot pump blood effectively)
  • Allograft failure (failure of a transplanted lung)
  • Peripheral embolism—when pieces of the clot break off and travel through the bloodstream, potentially causing:
    • Limb ischemia (reduced blood flow to arms or legs)
    • Stroke
    • Renal infarction (kidney damage)

The risk of peripheral embolization and acute stroke makes this condition particularly dangerous, as these complications can have catastrophic results if not prevented or treated promptly.

Treatment Options

Treatment for pulmonary venous thrombosis must be tailored to the specific underlying cause and the individual patient's situation. The approach depends on what is causing the blockage and how severe the condition is.

Treatment options may include:

  • Antibiotic therapy—if infection is present or suspected
  • Anticoagulation—medications that prevent blood from clotting, often called "blood thinners," though they do not actually thin the blood but rather slow down the clotting process
  • Thrombectomy—a surgical or minimally invasive procedure to physically remove the blood clot
  • Pulmonary resection—surgical removal of part of the lung if necessary

The choice of treatment depends on several factors, including the location and size of the clot, whether the patient has bleeding risks, and the presence of other medical conditions. Management must be individualized based on the underlying pathology causing the thrombosis.

Because this condition is rare and potentially fatal, increased clinical awareness and comprehensive diagnostic approaches are essential to prevent severe consequences.

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Pulmonary venous thrombosis

Recruiting trials first

See all 1 trials →
Quick filters

1 clinical trial in this condition

Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Rosuvastatin Calcium
  • Sponsor:Centre Hospitalier Regional Et Universitaire De Brest
See all 1 trials →filters applied: condition = Pulmonary venous thrombosis

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).